Healthcare > Medical Devices & Equipment
•1105 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1105)
| Company | Market Cap | Price |
|---|---|---|
|
NNE
Nano Nuclear Energy Inc
Company engages in laboratory testing/advisory services related to nuclear tech development and regulatory readiness.
|
$1.18B |
$26.58
-6.70%
|
|
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Core product is Cardiology devices: wearable defibrillator (ASSURE WCD) and related cardiac therapy platform.
|
$1.18B |
$22.87
-0.48%
|
|
BLFS
BioLife Solutions, Inc.
Sells consumables such as hPL, CellSeal vials, and CryoCase used within CGT workflows.
|
$1.17B |
$24.41
-0.27%
|
|
CSTL
Castle Biosciences, Inc.
Provides laboratory-based molecular diagnostic testing and related advisory services directly to clinicians.
|
$1.16B |
$39.98
-1.88%
|
|
SSII
SS Innovations International, Inc.
Core product: robotic surgical system and endo-surgical instruments (SSi Mantra and related tools) sold as surgical equipment.
|
$1.15B |
$5.88
+6.43%
|
|
THRM
Gentherm Incorporated
Medical devices & biometrics including patient temperature management devices.
|
$1.13B |
$36.92
-2.97%
|
|
SPRY
ARS Pharmaceuticals, Inc.
Neffy includes a needle-free delivery device, aligning with Medical Devices & Biometrics.
|
$1.10B |
$11.36
+1.88%
|
|
ACHC
Acadia Healthcare Company, Inc.
ACHC operates hospital services focused on behavioral health, including inpatient psychiatric facilities.
|
$1.08B |
$11.67
-2.02%
|
|
CDNA
CareDx, Inc
Directly provides Laboratory Testing & Advisory Services through its testing portfolio and diagnostic operations.
|
$1.07B |
$20.00
-2.77%
|
|
BFLY
Butterfly Network, Inc.
Core ultrasound imaging hardware and point-of-care devices (POCUS) produced by Butterfly.
|
$1.05B |
$4.14
-9.01%
|
|
EYPT
EyePoint Pharmaceuticals, Inc.
Implantable ophthalmic device component due to bioerodible Durasert E delivery system.
|
$1.04B |
$15.08
-4.80%
|
|
STAA
STAAR Surgical Company
STAAR directly manufactures ophthalmic medical devices, primarily implantable lenses (EVO ICL) used for vision correction.
|
$1.04B |
$20.98
+0.05%
|
|
ALNT
Allient Inc.
Medical Device Components align with Allient’s product capabilities used in medical device applications.
|
$1.04B |
$61.37
-0.72%
|
|
OPK
OPKO Health, Inc.
OPKO's BioReference segment provides laboratory testing and advisory services.
|
$1.02B |
$1.29
+0.78%
|
|
MRVI
Maravai LifeSciences Holdings, Inc.
Biologics safety testing kits and related analytical services (e.g., residual DNA quantification, Protein L assays) are direct BST offerings.
|
$1.00B |
$3.93
+6.50%
|
|
IART
Integra LifeSciences Holdings Corporation
Direct neurosurgery devices and surgical implants (e.g., CerebroFlo EVD catheter, Aurora Surgiscope) are core products.
|
$966.87M |
$12.40
-1.98%
|
|
PLSE
Pulse Biosciences, Inc.
Pulse Biosciences develops nsPFA-based medical devices (e.g., CellFX platform) for non-thermal tissue ablation across soft tissue and cardiac indications.
|
$958.72M |
$14.25
+1.06%
|
|
CLB
Core Laboratories N.V.
CLB provides laboratory testing and advisory services via proprietary tracers and reservoir analysis capabilities.
|
$911.15M |
$19.46
-0.82%
|
|
INMD
InMode Ltd.
InMode's core business is medical devices and biometrics, with RF-based aesthetic platforms and related systems.
|
$881.73M |
$13.95
-0.71%
|
|
PSNL
Personalis, Inc.
NeXT Personal is a tumor-informed liquid biopsy-based MRD test, central to PSNL's offerings.
|
$877.02M |
$9.89
+2.91%
|
|
PCRX
Pacira BioSciences, Inc.
IOvera is a medical device product, placing Pacira in the Medical Devices & Biometrics category.
|
$860.91M |
$19.14
-7.31%
|
|
FLGT
Fulgent Genetics, Inc.
Laboratory testing and advisory services.
|
$859.50M |
$28.10
-1.92%
|
|
NUTX
Nutex Health, Inc.
Nutex Health operates micro-hospitals and provides hospital services including acute inpatient care and emergency/observation services.
|
$850.27M |
$153.45
-6.55%
|
|
MATW
Matthews International Corporation
Memorialization segment includes embalming chemicals and funeral supplies (memorialization products).
|
$842.44M |
$27.35
-4.67%
|
|
CBLL
CeriBell, Inc.
Ceribell's core product is a point-of-care diagnostic EEG system (diagnostic equipment).
|
$804.41M |
$21.97
-3.81%
|
|
BBNX
Beta Bionics, Inc.
Core product is a medical device (iLet Bionic Pancreas) and related biometrics in diabetes care.
|
$804.20M |
$18.53
+4.16%
|
|
MDXG
MiMedx Group, Inc.
Directly manufactures and sells wound care devices and placental tissue allografts (EPIFIX, EPICORD, EPIEFFECT) used in wound healing.
|
$801.94M |
$5.42
-5.74%
|
|
MEG
Montrose Environmental Group, Inc.
Laboratory testing and advisory services as part of Montrose's measurement and analysis offerings.
|
$770.30M |
$21.84
-7.50%
|
|
KE
Kimball Electronics, Inc.
KE's medical device and biometrics manufacturing capabilities are central to its strategy.
|
$746.66M |
$30.75
-2.01%
|
|
SIBN
SI-BONE, Inc.
SI-BONE operates as a medical device company that designs, develops and sells orthopedic implants and related medical devices.
|
$733.40M |
$17.02
-3.19%
|
|
EMBC
Embecta Corp.
Embecta operates as a medical device company focused on insulin injection devices, including pen needles, syringes, and safety products.
|
$724.63M |
$12.41
-1.51%
|
|
CTKB
Cytek Biosciences, Inc.
Cytek's instrument manufacturing includes flow cytometry diagnostic equipment, the core product line referenced in the article.
|
$687.01M |
$5.40
-3.91%
|
|
TCMD
Tactile Systems Technology, Inc.
Core medical devices for lymphedema and airway clearance (Flexitouch Plus, Nimbl, AffloVest) are manufactured and sold by the company.
|
$679.02M |
$30.43
-0.20%
|
|
PACB
Pacific Biosciences of California, Inc.
PacBio directly manufactures diagnostic sequencing equipment (instruments) used in molecular diagnostics and research laboratories.
|
$663.82M |
$2.21
-5.74%
|
|
BVS
Bioventus Inc.
Bioventus designs and manufactures medical devices and biometrics solutions for musculoskeletal health.
|
$655.64M |
$7.94
-0.63%
|
|
SRDX
Surmodics, Inc.
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are a core product category sold by the company.
|
$614.58M |
$42.98
|
|
LAB
Standard BioTools Inc.
SomaScan laboratory testing and advisory services are a core direct offering.
|
$595.91M |
$1.56
-1.27%
|
|
VPG
Vishay Precision Group, Inc.
Medical infusion pump design win indicates participation in the Medical Devices & Biometrics market.
|
$579.10M |
$43.62
-0.18%
|
|
AVNS
Avanos Medical, Inc.
The RFA portfolio (ESENTEC, TRIDENT, COOLIEF) places Avanos in the neuromodulation devices category.
|
$572.61M |
$12.34
|
|
VREX
Varex Imaging Corporation
Core Medical Imaging category representing imaging hardware and components used in medical devices.
|
$572.28M |
$13.81
-0.36%
|
|
NUS
Nu Skin Enterprises, Inc.
The Prysm iO and related wellness devices involve medical/biometric device technology.
|
$571.20M |
$11.54
+1.72%
|
|
DBVT
DBV Technologies S.A.
Viaskin patch is a medical device delivering therapy; categorize under Medical Devices & Biometrics.
|
$569.26M |
$20.74
+10.32%
|
|
DNA
Ginkgo Bioworks Holdings, Inc.
Laboratory Testing & Advisory Services aligns with CRO-type fee-for-service capabilities.
|
$565.36M |
$9.56
-0.16%
|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$560.40M |
$16.98
-2.13%
|
Showing page 5 of 12 (1105 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
